A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: A randomized, open-label, crossover study in subjects with diabetes

Diabetes Technology and Therapeutics

Volumn 11, Issue 3, 2009, Pages 195-201

  McKay, Maureen ^a   Compion, Gerhard ^b   Lytzen, Lene ^c  

^a ST JOHN'S HOSPITAL   (United Kingdom)

^b Novo Nordisk Ltd   (United Kingdom)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; EXPERIENCE; FEMALE; HUMAN; INJECTION SITE PAIN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEEDLE; NOCICEPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; NEEDLES; PAIN; PERCEPTION; QUESTIONNAIRES; THIGH;

EID: 62249202141     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2008.0054     Document Type: Article

References (12)

1. Nakar S, Yitzhaki G, Rosenberg R, Vinker S: Transition to insulin in type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers. J Diabetes Complications 2007;21:220-226.
2. Hanas R, Ludvigsson J: Experience of pain from insulin injections and needle-phobia in young patients with IDDM. Pract Diabetes Int 1997;14:95-99.
3. Zambanini A, Newson RB, Maisey M, Feher MD: Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999;46:239-246.
4. Egekvist H, Bjerring P, Arendt-Nielsen L: Pain and mechanical injury of human skin following needle insertions. Eur J Pain 1999;3:41-49.
5. Arendt-Nielsen L, Egekvist H, Bjerring P: Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res 2006;23:37-43.
6. Schwartz S, Hassman D, Shelmet J, Sievers R, Weinstein R, Liang J, Lyness W: A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus. Clin Ther 2004;26:1663-1678.
7. Tubiana-Rufi N, Belarbi N, Du Pasquier-Fediaevsky L, Polak M, Kakou B, Leridon L, Hassan M, Czernichow P: Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care 1999;22:1621-1625.
8. Molin A, Larsen C, Lawton SA: Reduced flow resistance in insulin pen needles designed with thin wall technology [abstract]. Diabetes 2002;51(Suppl 2):A475.
9. Chantelau E, Lee DM, Hemmann DM, Zipfel U, Echterhoff S: What makes insulin injections painful? BMJ 1991;303:26-27.
10. Jamal R, Ross SA, Parkes JL, Pardo S, Ginsberg BH: Role of injection technique in use of insulin pens: prospective evaluation of a 31-gauge, 8-mm insulin pen needle. Endocr Pract 1999;5:245-250.
11. Hanas R, Lytzen L, Ludvigsson J: Thinner needles do not influence injection pain, insulin leakage or bleeding in children and adolescents with type 1 diabetes. Pediatr Diabetes 2000;1:142-149.
12. Iwanaga M, Kamoi K: Effect of NovoFine® 32G 6mm and Micro Fine Plus 31G 5mm needles on patient perceptions of pain and anxiety [abstract]. Diabetes 2006;55(Suppl 1):A458.